[ET Net News Agency, 7 August 2024] SINOPHARM (01099) rose 3.1% to HK$19.42, breaking
above the 20-D SMA of HK$18.887.
It hits an intra-day high of HK$19.42, and an intra-day low of HK$18.88. The total
shares traded was 2.49 million, with a value of HK$47.94m. The active buy/sell ratio is
56:44, with net buying turnover of HK$5.3m. J.P. MORGAN BRO (HK) accounts for greatest net
responsive buying turnover of HK$3.09m, with volume weighted average price of HK$19.252.
BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$2.25m,
with volume weighted average price of HK$19.263. The stock has risen a combined 8.9% over
the past 6 consecutive trading days.
The Hang Seng Index now rose 333 points, or 2% to 16,980.

Basic Information
=================

---------------------------------
Nominal 19.420 % Chg +3.08%
High 19.420 Low 18.880
Shares Tr 2.49m Turnover 47.94m
10-D SMA 18.552 %H.V 21.814
20-D SMA 18.887 VWAP 19.252
50-D SMA 20.021 RSI14 53.269
---------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 56:44, with net buying
turnover of HK$5.3m, rising a combined 8.9% over the past 6 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
SINOPHARM (01099) 19.42 +3.08
ALI HEALTH (00241) 3.29 -0.30
TRAD CHI MED (00570) 3.53 +2.02
CSPC PHARMA (01093) 5.95 +1.88
SINO BIOPHARM (01177) 2.87 Unchanged
CHINARES PHARMA (03320) 5.61 +2.94
HANSOH PHARMA (03692) 18.64 +1.19
JD HEALTH (06618) 21.85 +0.23
GOLDEN THROAT (06896) 3.08 Unchanged
DINGDANG HEALTH (09886) 1.16 +5.45
-----------------------------------------------
(ed)